1144
K. I. Sathiyanarayanan, N. S. Karthikeyan, P. G. Aravindan,
S. Shanthi, R. S. Rathore, and C. W. Lee
Vol 46
Table 1
2.97 (m, 4H), 3.48 (s, 1H, NH), 3.81–4.01 (s, 6H), 4.52–4.55
(d, 1H), 5.75 (d, 1H), 6.66–7.60 (m, 12H).
Reaction of 2-tetralone with benzaldehydes.
Aldehyde
Product
Yield
REFERENCES AND NOTES
Benzaldehyde (1a)
4a
4b
4c
5d
5e
86%
74%
76%
68%
65%
[1] Atwell, G. J.; Baguley, B. C.; Denny, W. A. J Med Chem
1988, 31, 774.
p-Chlorobenzaldehyde (1b)
p-Methoxybenzaldehyde (1c)
o-Chlorobenzaldehyde (1d)
o-Methoxybenzaldehyde (1e)
[2] Cappelli, A.; Anzini, M.; Vomero, S.; Mannuni, L.; Mako-
vec, F.; Doucet, E.; Hamon, M.; Bruni, G.; Romeo, M. R.; Menziani,
M. C.; Benedetti, P. G.; Langer, T. J Med Chem 1998, 41, 728.
[3] Janin, Y. L.; Croisy, A.; Riou, J.-F.; Bisagni, E. J Med
Chem 1993, 36, 3686.
[4] Simanek, V. In The Alkaloids; Bross, A., Ed.; Academic:
New York, 1985; Vol. 26, p 185.
reported method provides a potential utility of chemistry
in organic synthesis.
[5] Suffiness, W. M.; Gordell, G. A. In The Alkaloids; Bross,
A., Ed.; Academic: New York,1983; Vol. 25, p 178.
[6] Shamma, M. The Isoquinoline Alkaloids: Chemistry and
Pharmacology; Academic Press: New York, 1972.
[7] Shamma, M.; Moniot, J. L. Isoquinoline Alkaloids
Research, 1972–1977; Plenum Press: New York, 1978.
[8] Li, D. J.; Zhao, B.; Sim, S. P.; Li, T. K.; Liu, L. F.;
LaVoie, E. J. Bioorg Med Chem 2003, 11, 3795.
EXPERIMENTAL
General procedure. 0.2M of respective benzaldehyde was
treated with 0.1M of 2-tetralone and 0.1M of ammonium ace-
tate in 15 mL of ethanol. The mixture was gently warmed in a
water bath until the color changed to orange and kept aside for
overnight at room temperature. The completion of the reaction
was identified with TLC. The solid obtained was separated and
the crude compound was purified by silica gel column chroma-
tography using hexane and ethyl acetate as elutant.
[9] Zhou, Y.; Baker, W.; Kazmaier, E. P. M.; Buncel, E. Can J
Chem 1998, 76, 884.
[10] Gorner, H.; Dopp, D.; Dittmann, A. J Chem Soc Perkin
Trans 2 2000, 1723.
[11] Aimone, S. L.; Caram, J. A.; Mirifico, M. V.; Vasini, E. J.
J Phys Org Chem 2000, 13, 272.
[12] (a) Kuznetsova, L. P.; Nikol’skaya, E. B.; Sochilina, E. E.;
Faddeeva, M. D. Tsitologiya 2001, 43, 1046; (b) Kuznetsova, L. P.;
Nikol’skaya, E. B.; Sochilina, E. E.; Faddeeva, M. D. Chem Abstr
137, 210505.
Spectral data
5-Phenyl-7,8,13,14-tetrahydrodibenzo[a,i]phenanthridine
(4a). Crystal; mp 170ꢀC; IR (KBr): 3057, 2833, 1606, 1549,
1
1425, 1396, 1245 cmꢁ1; H NMR (CDCl3, 400 MHz): d 2.76–
[13] Hoffmann, T. K.; Leenen, K.; Hafner, D.; Balz, V.; Ger-
harz, C. D.; Grund, A.; Ballo, H.; Hauser, U.; Bier, H. Anti Cancer
Drugs 2002, 13, 93.
3.20 (m, 8H), 7.00–7.53 (m, 13H); 13C NMR (CDCl3, 100
MHz): d 24.79, 27.41, 29.53, 31.38,124.68, 125.60, 126.30,
126.92, 127.25, 127.64, 127.75, 128.33, 128.68, 129.62,
129.80, 130.58, 132.77, 133.04, 136.99, 138.68, 139.43,
139.67, 140.29, 142.06, 145.65, 153.95, 158.08.
[14] (a) Taniguchi, Y.; Koyama, T.; Adachi, C.; Saitou, T.;
Satsuki, M.; Shinpo, A.; Tokito, S.; Fujikawa, H.; Noda, K.; Miura,
A.; Taga, Y. (Kabushiki Kaisha Hayashibara Seibutsu Kagaku Ken-
kyujo, Japan) U.S. Pat.20,020,502 (2002); (b) Taniguchi, Y.;
Koyama, T.; Adachi, C.; Saitou, T.; Satsuki, M.; Shinpo, A.; Suga,
S.; Tokito, S.; Fujikawa, H.; Noda, K.; Miura, A.; Taga, Y. Chem
Abstr 136, 348078.
5-(p-Chlorophenyl)-7,8,13,14-tetrahydrodibenzo[a,i]phenan-
thridine (4b). Crystal; mp 178ꢀC; IR (KBr): 3032, 2833, 1605,
1
1549, 1425, 1358, 1245, 763 cmꢁ1; H NMR (DMSO-d6, 300
MHz): d 2.54 (m, 2H), 2.74–3.26 (m, 6H), 7.12–7.61 (m,
12H); MS (LC-MS): m/z ¼ 394 (Mþ).
[15] Kock, I.; Clement, B. Synthesis 2005, 7, 1052.
[16] Churruca, F.; Martin, R. S.; Carril, M.; Urtiaga, M. K.; Sol-
ans, X.; Tellitu, I.; Dominguez, E. J Org Chem 2005, 70, 3178.
[17] Feng, W.; Satyanarayana, M.; Tsai, Y.-C.; Liu, A. A.; Liu,
L. F.; Lavoie, E. J. Bioorg Med Chem 2008, 16, 8598.
[18] Buden, M. E.; Rossi, R. A. Tetrahedron Lett 2007, 48, 8739.
[19] Kohno, K.; Azuma, S.; Choshi, T.; Nobuhiro, J.; Hibino, S.
Tetrahedron Lett 2009, 50, 590.
5-(p-Methoxyphenyl)-7,8,13,14-tetrahydrodibenzo[a,i]phe-
nanthridine (4c). Crystal; mp 174ꢀC; IR (KBr) 3032, 2833,
1
1606, 1549, 1425, 1358, 1245 cmꢁ1; H NMR (DMSO-d6, 400
MHz): d 2.50–3.08 (m, 8H), 3.78 (s, 3H), 6.86–6.91 (m, 4H),
7.29–7.32 (m, 8H); MS (LGC-MS): m/z ¼ 390 (Mþ).
2,4-Di(o-chlorophenyl)-6,7-benzo-3-azabicyclo[3.3.1]nonan-
9-one (5d). Crystal; mp 230ꢀC; IR (KBr): 3309, 2846, 1711,
[20] Herrera, A.; Alvarez, R. M.; Chioua, M.; Chatt, R.; Chioua,
R.; Sanchez, A.; Almy, J. Tetrahedron 2006, 62, 2799.
[21] Prado, S.; Michel, S.; Tillequin, F.; Koch, M.; Pfeiffer, B.;
Pierre, A.; Leonce, S.; Colson, P.; Baldeyrou, B.; Lansiaux, A.; Bailly,
C. Bioorg Med Chem 2004, 12, 3943.
1423, 1243, 751 cmꢁ1 1H NMR (DMSO-d6, 300 MHz): d
;
2.92–3.15 (m, 4H), 3.56 (s, 1H, NH), 4.59–4.62 (d, 1H), 5.73–
5.76 (d, 1H), 6.74–7.78 (m, 12H).
2,4-Di(o-methoxyphenyl)-6,7-benzo-3-azabicyclo[3.3.1]nonan-
9-one (5e). Crystal; mp 220ꢀC; IR (KBr) 3313, 2832, 1715,
[22] Mehta, K. B.; Kumamoto, K.; Yanagisawa, K.; Kotsuki, H.
Tetrahedron Lett 2005, 46, 6953.
1491, 1243 cmꢁ1
;
1H NMR (DMSO-d6, 300 MHz): d 2.48–
[23] Noller, C. R.; Baliah, V. J Am Chem Soc 1948, 70, 3853.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet